Please assess the completion status of the following clinical trial:

Trial Title: Esophageal Hypersensitivity Study in Healthy Volunteers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Provision of written consent~* Clinically normal physical findings~* Sensitization potential~Exclusion Criteria:~* Clinically significant illness within 2 weeks prior to the first dose of investigational product~* History of clinically significant disease~* Use of prescribed medication during the 2 weeks before administration of the first dose of investigational product

- Gender: MALE
- Minimum Age: 20 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): 30 mg, oral, single dose
- 2 (Type: EXPERIMENTAL): 95 mg, oral, single dose
- 3 (Type: PLACEBO_COMPARATOR): Oral solution, single dose

Based on this trial design, predict the completion outcome and termination type (if applicable).